US2021085870A1PendingUtilityA1

Systems and methods for determining insulin therapy for a patient

58
Assignee: MONARCH MEDICAL TECH LLCPriority: Dec 21, 2011Filed: Nov 20, 2020Published: Mar 25, 2021
Est. expiryDec 21, 2031(~5.4 yrs left)· nominal 20-yr term from priority
G16Z 99/00G06Q 50/22G16H 50/20A61M 5/1723G16H 10/40A61B 5/14532G16H 20/17A61B 5/7275
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A non-transitory computer readable medium having stored therein instructions executable by a computing device to cause the computing device to perform functions comprising:
 receive a selection from a user of an insulin dosing model;   prompt the user to provide information specific to a patient based on the selection;   generate an insulin dosage recommendation based on the selection and the information specific to the patient; and   provide a graphical user interface customized to the insulin dosing model and configured to display the insulin dosage recommendation to the user.   
     
     
         2 . The non-transitory computer readable medium of  claim 1 , wherein the insulin dosing model comprises an intravenous insulin dosing model and the insulin dosage recommendation comprises an intravenous insulin dosage recommendation. 
     
     
         3 . The non-transitory computer readable medium of  2 , wherein the information specific to the patient comprises a current insulin infusion rate and a glucose measurement used to determine the current insulin infusion rate. 
     
     
         4 . The non-transitory computer readable medium of  claim 1 , wherein the insulin dosing model comprises a subcutaneous insulin dosing model and the insulin dosage recommendation comprises a subcutaneous insulin dosage recommendation. 
     
     
         5 . The non-transitory computer readable medium of  claim 4 , wherein the information specific to the patient comprises a total basal insulin units administered per day and a total bolus insulin units administered per day. 
     
     
         6 . The non-transitory computer readable medium of  claim 1 , wherein the insulin dosing model comprises a starting insulin dosing model and the insulin dosage recommendation comprises an intravenous insulin dosage recommendation or a subcutaneous insulin dosage recommendation. 
     
     
         7 . The non-transitory computer readable medium of  claim 6 , wherein the information specific to the patient comprises demographic information and clinical information. 
     
     
         8 . The non-transitory computer readable medium of  claim 1 , wherein the information specific to the patient comprises a diabetes diagnosis, a potassium level, a weight, a targeted blood glucose range, a creatinine level, a date of birth, a sex, or combinations thereof. 
     
     
         9 . The non-transitory computer readable medium of  claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:
 receive additional information specific to the patient from a hospital information system communicatively coupled to the computing device.   
     
     
         10 . The non-transitory computer readable medium of  claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:
 disseminate an order embodying the insulin dosage recommendation to various locations within a hospital equipped to execute the order.   
     
     
         11 . The non-transitory computer readable medium of  claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:
 receive a current glucose level from a continuous glucose monitor connected to the patient.   
     
     
         12 . The non-transitory computer readable medium of  claim 1 , wherein the insulin dosage recommendation is executable by an insulin delivery device. 
     
     
         13 . The non-transitory computer readable medium of  claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:
 generate a carbohydrate dosage recommendation based at least in part on the information specific to the patient.   
     
     
         14 . The non-transitory computer readable medium of  claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:
 generate an instruction indicating when a next glucose measurement should be obtained.   
     
     
         15 . The non-transitory computer readable medium of  claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:
 cause the graphical user interface to display a request for additional information, a therapy recommendation, or both when an unexpected glucose value is measured after the insulin dosage recommendation is implemented.   
     
     
         16 . The non-transitory computer readable medium of  claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:
 cause the graphical user interface to display a first interface when the insulin dosing model comprises an intravenous insulin doing model and a second interface, different from the first, when the insulin dosing model comprises a subcutaneous insulin dosing model.   
     
     
         17 . The non-transitory computer readable medium of  claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:
 receive a selection of a hospital and a selection of a unit within the hospital where the patient is located.   
     
     
         18 . The non-transitory computer readable medium of  claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:
 determine that a most recent glucose measurement was received longer than a maximum length of time before a current time,   wherein the insulin dosing model comprises a restarting insulin dosing model.   
     
     
         19 . The non-transitory computer readable medium of  claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:
 generate an alert for visual display or audible transmission to the user when a glucose check is past due.   
     
     
         20 . The non-transitory computer readable medium of  claim 1 , wherein the instructions are executable to cause the computing device to operate without connecting to a server or a hospital information system.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.